Pseudophakic cystoid macular edema

International Ophthalmology Clinics

Volumn 50, Issue 1, 2010, Pages 139-153

  Benitah, Nicole R ^a   Arroyo, Jorge G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BETAMETHASONE; CORTICOSTEROID; DICLOFENAC; FLUOROMETHOLONE; FLURBIPROFEN; INDOMETACIN; KETOROLAC; METHYLPREDNISOLONE; NEPAFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; TRIAMCINOLONE; VALDECOXIB; VASCULOTROPIN;

CLINICAL TRIAL; DRUG DOSE REDUCTION; HUMAN; INCIDENCE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PSEUDOPHAKIA; RETINA MACULA CYSTOID EDEMA; REVIEW; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS; HUMANS; INCIDENCE; MACULAR EDEMA; PROGNOSIS; PSEUDOPHAKIA; RISK FACTORS; UNITED STATES; VITRECTOMY;

EID: 75149130575     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181c551da     Document Type: Review

References (74)

1. Irvine S. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:599-619.
2. Gass JDM, Norton EW. Cystoid macular edema and papilledema following cataract extraction. Arch Ophthalmol. 1966;76:646-660.
3. Donnenfeld E. CME from the anterior segment surgeon's perspective. Retina Today. 2008:60-62.
4. Flach AJ. The incidence, pathogenesis, and treatment of cystoid macular edema following cataract surgery. Transact Am Ophthalmol Soc. 1998;96:557-634.
5. Miyake K, Sugiyama S, Norimatsu I, et al. Aqueous prostaglandins in persistent cystoid macular edema secondary to vitreous incarceration: effects of pars plana vitrectomy. Jpn J Ophthalmol. 1980;24:335-345.
6. Kremer M, Baikoff G, Charbonnel B. The release of prostaglandins in human aqueous humour following intraocular surgery: effect of indomethacin. Prostaglandins. 1982;23:695-702.
7. Thomas MA, O'Grady GE, Swartz SL. Prostaglandin levels in human vitreous. Br J Ophthalmol. 1985;69:275-279.
8. Arcieri ES, Santana A, Rocha FN, et al. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia. Arch Ophthalmol. 2005;123:186-192.
9. Schepens CL, Avila MP, Jalkh AE, et al. Role of the vitreous in cystoid macular edema. Surv Ophthalmol. 1984;28(suppl):499-504.
10. Gulkilik G, Kocabora S, Taskapili M, et al. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Canadian J Ophthalmol. 2006;41:699-703.
11. Pollack A, Leiba H, Bukelman A, et al. Cystoid macuclar oedema following cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76:221-224.
12. Jain R, Stevens JD, Bunce CV, et al. Ischaemic heart disease may predispose to pseudophakic cystoid macular oedema. Eye. 2001;15:34-38.
13. Gass JDM, Norton EW. Follow-up study of cystoid macular edema following cataract extraction. Transact Am Acad Ophthalmol Otolaryngol. 1969;73:665-682.
14. Henderson BA, Kim JY, Ament CS, et al. Clinical pseudophakic cystoid macular edema; risk factors for development and duration after treatment. J Cataract Refract Surg. 2007;33:1550-1558.
15. Miyake K, Ota I, Maekubo K, et al. Latanoprost accelerates disruption of the bloodaqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 1999;117:34-40.
16. Dhingra N, Morgan JE. Pseudophakic cystoid macular oedema: 30 months after latanoprost challenge. Eye. 2006;21:269-271.
17. Altintas O, Yüksel N, Karabas VL, et al. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery. Eur J Ophthalmol. 2005;15:158-161.
18. Yeh PC, Ramanathan S. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. J Cataract Refract Surg. 2002;28:1814-1818.
19. Masood I, Negi A, Vernon SA, et al. The-174G/C interleukin-6 promoter polymorphism influences the development of macular oedema following uncomplicated phacoemulsification surgery. Eye. 2007;21:1412-1415.
20. Ursell PG, Spalton DJ, Whitcup SM, et al. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25:1492-1497.
21. Klein RM, Yannuzzi L. Cystoid macular edema in the first week after cataract extraction. Am J Ophthalmol. 1976;81:614-615.
22. Jampol LM, Kraff MC, Sanders DR, et al. Near-UV radiation from the operating microscope and pseudophakic cystoid macular edema. Arch Ophthalmol. 1985;103: 28-30.
23. Kraff MC, Sanders DR, Jampol LM, et al. Effect of an ultraviolet- filtering intraocular lens on cystoid macular edema. Ophthalmology. 1985;92:366-369.
24. Komatsu M, Kanagami S, Shimizu K. Ultraviolet-absorbing intraocular lenses versus non-UV-absorbing intraocular lens: comparison of angiographic cystoid macular edema. J Cataract Refract Surg. 1989;15:654-657.
25. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology. 1999;106:1660-1664.
26. Gouws P, Merriman M, Goethals S, et al. Cystoid macular oedema with trypan blue use. Br J Ophthalmol. 2004;88:1348-1355.
27. Spaide RA, Yannuzzi LA, Sisco LJ. Chronic cystoid macular edema and predictors of visual acuity. Ophthalmic Surg. 1993;24:262-267.
28. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002; 17:167-180.
29. Wolf EJ, Braunstein A, Shih C, et al. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. J Cataract Refract Surg. 2007;33:1546-1549.
30. Jacobson DR, Dellaporta A. Natural history of cystoid macular edema after cataract extraction. Am J Ophthalmol. 1974;77:445-447.
31. Bradford JD, Wilkinson CP, Bradford RH. Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina. 1988;8:161-164.
32. Benhamou N, Massin P, Haouchine B, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135:246-249.
33. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 2003;136:384-386. (Pubitemid 36904101)
34. Koutsandrea C, Moschos MM, Brouzas D, et al. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema. Retina. 2007;27:159-164.
35. Konstantopoulos A, Williams CP, Luff AJ. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema. Eye. 2008;22:219-222.
36. Abe T, Hayasaka S, Nagaki Y, et al. Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone. J Cataract Refract Surg. 1999;25:1286-1288.
37. Peterson M, Yoshizumi MO, Hepler R, et al. Topical indomethacin in the treatment of chronic cystoid macular edema. Graefe Arch Clin Exp Ophthalmol. 1992;230:401-405.
38. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 1991;112:514-519.
39. Weisz JM, Bressler NM, Bressler SB, et al. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Ophthalmology. 1999;106:1656-1659.
40. Singal N, Hopkins J. Pseudophakic cystoid macular edema: ketorolac alone versus ketorolac plus prednisolone. Canadian J Ophthalmol. 2004;39:245-250.
41. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 2000;107:2034-2039.
42. Warren KA, Fox JE. Topical nepafenac as an alternative treatment for cystoid macular edema in steroid responsive patients. Retina. 2008;28:1427-1434.
43. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29:2378-2384.
44. Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. J Cataract Refract Surg. 1995;21:73-81.
45. Rossetti L, Bujtar E, Castoldi D, et al. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. J Cataract Refract Surg. 1996;22:794-799.
46. Group IDS. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J Cataract Refract Surg. 1997;23: 1183-1189.
47. Donnenfeld ED, Perry HD, Wittpenn JR, et al. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg. 2006;32:1474-1482.
48. Yavas GF, Oztürk F, Kusbeci T. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg. 2007;33:804-807.
49. Miyake K, Nishimura K, Harino S, et al. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation. Invest Ophthalmol Vis Sci. 2007;48:5647-5652.
50. Asano S, Miyake K, Ota I, et al. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation. J Cataract Refract Surg. 2008;34:57-63.
51. Almeida DRP, Johnson D, Hollands H, et al. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg. 2008;34:64-69.
52. Reis A, Birnbaum F, Hansen LL, et al. Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery. J Cataract Refract Surg. 2005;31:1437-1440.
53. Reis A, Birnbaum F, Hansen LL, et al. Successful treatment of cystoid macular edema with valdecoxib. J Cataract Refract Surg. 2007;33:682-685. (Pubitemid 46482966)
54. Riley AF, Wakely LA, Patel HY, et al. Use of a cyclo0oxygenase 2 inhibitor for prophylaxis of cystoid macular oedema following cataract surgery: a randomized placebo-controlled trial. Clin Exp Ophthalmol. 2006;34:299-304.
55. Farber MD, Lam S, Tessler HH, et al. Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. Br J Ophthalmol. 1994;78:4-7.
56. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 1988;106:1190-1195.
57. Fishman GA, Gilbert LD, Fiscella RG, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 1989;107:1445-1452.
58. Grover S, Fishman GA, Fiscella RG, et al. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina. 1997;17:222-231.
59. Whitcup SM, Csaky KG, Podgor MJ, et al. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology. 1996;103:1054-1062.
60. Wolfensberger TJ. The role of carbonic anhydrase inhibitors in the management of macular edema. Documenta Ophthalmalogica. 1999;97:387-397.
61. Tripathi RC, Fekrat S, Tripathi BJ, et al. A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy. Ann Ophthalmol. 1991;23:127-129.
62. Ismail RA, Sallam A, Zambarakji HJ. Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. Eur J Ophthalmol. 2008;18:1011-1013.
63. Mason JO, Albert MA Jr, Vail R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina. 2006;26:356-357.
64. Arevalo JF, Garcia-Amaris RA, Roca JA, et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema. J Cataract Refract Surg. 2007;33:2098-2105.
65. Spitzer MS, Ziemssen F, Yoeruek E, et al. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg. 2008;34:70-75.
66. Barone A, Prascina F, Russo V, et al. Successful treatment of pseudophakic cystoid macular edema with intravitreal bevacizumab. J Cataract Refract Surg. 2008;34: 1210-1212.
67. Rotriguez-Blanco M, Marticorena J, Gomez-Ulla F. Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab. Graefe Arch Clin Exp Ophthal. 2009;247:427-428.
68. Barone A, Russo V, Prascina F, et al. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema. Retina. 2009;29:33-37.
69. Cervera E, Diaz-Llopis M, Udaondo P, et al. Intravitreal pegaptanib sodium for refractory pseudophakic macular oedema. Eye. 2008;22:1180-1182.
70. Fung W. The national, prospective, randomized vitrectomy study for chronic phakic cystoid macular edema. Progress report and comparison between the control and nonrandomized groups. Surv Ophthalmol. 1984;28 (suppl):569-575.
71. Fung WE. Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology. 1985;92:1102-1111.
72. Harbour JW, Smiddy WE, Rubsamen PE, et al. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1995;120:302-307.
73. Pendergast SD, Margherio RR, Williams GA, et al. Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol. 1999;128:317-323.
74. Peyman GA, Canakis C, Livir-Rallatos C, et al. The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular edema: a report of two cases. Am J Ophthalmol. 2002;133:571-572.